NASDAQ : ZYME
Zymeworks Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 28.71 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.04B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Zymeworks Inc. (ZYME) reported revenue of 37.13M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 37.13M | 105.97M | 76.30M | 76.01M | 412.48M | 26.68M |
| Cost of Revenue | 128.71M | 137.00M | 136.50M | 142.99M | 208.85M | 199.54M |
| Gross Profit | -91.58M | -31.04M | -60.20M | -66.98M | 203.64M | -172.86M |
| Selling, General & Admin | 63.98M | 61.51M | 61.51M | 70.45M | 73.36M | 42.56M |
| Operating Expenses | 63.98M | 61.51M | 61.51M | 70.45M | 73.36M | 42.43M |
| Operating Income | -155.56M | -92.55M | -121.70M | -137.42M | 130.28M | -215.29M |
| Interest Expense | -8.66M | |||||
| Interest & Investment Income | 12.50M | 13.35M | 19.94M | 19.70M | 3.60M | 1.97M |
| Currency Exchange Gain (Loss) | -610.00K | -610.00K | 776.00K | -1.19M | 1.15M | 1.19M |
| Other Non Operating Income (Expenses) | 939.00K | 51.00K | -218.00K | 291.00K | -42.00K | -11.00K |
| EBT Excluding Unusual Items | -151.39M | -79.75M | -101.20M | -118.61M | 134.98M | -212.15M |
| Other Unusual Items | 1.88M | -630.00K | 250.00K | -213.00K | ||
| Pretax Income | -151.39M | -79.75M | -116.61M | -119.24M | 135.23M | -212.36M |
| Income Tax Expense | -1.40M | 1.38M | 6.08M | -568.00K | 10.89M | -516.00K |
| Net Income | -149.99M | -81.13M | -122.69M | -118.67M | 124.34M | -211.84M |
| Net Income to Common | -149.99M | -81.13M | -122.69M | -118.67M | 124.34M | -211.84M |
| Shares Outstanding (Basic) | 74.69M | 75.40M | 75.85M | 68.86M | 65.19M | 51.55M |
| Shares Outstanding (Diluted) | 74.69M | 75.41M | 75.88M | 68.86M | 65.25M | 52.13M |
| EPS (Basic) | -2.01 | -1.08 | -1.62 | -1.72 | 1.91 | -4.11 |
| EPS (Diluted) | -2.01 | -1.08 | -1.62 | -1.72 | 1.90 | -4.61 |
| Free Cash Flow | -120.54M | -34.53M | -112.05M | -120.80M | 135.96M | -204.85M |
| Free Cash Flow Per Share | -1.61 | -0.46 | -1.48 | -1.75 | 2.08 | -3.93 |
| Gross Margin | -246.66% | -29.29% | -78.89% | -88.11% | 49.37% | |
| Operating Margin | -418.99% | -87.34% | -159.50% | -180.79% | 31.58% | -806.94% |
| Profit Margin | -404.00% | -76.56% | -160.80% | -156.12% | 30.14% | -794.01% |
| Free Cash Flow Margin | -324.68% | -32.58% | -146.85% | -158.92% | 32.96% | -767.82% |
| EBITDA | -150.65M | -84.82M | -113.02M | -127.26M | 137.51M | -208.76M |
| EBITDA Margin | -80.05% | -148.11% | -167.42% | 33.34% | ||
| D&A For EBITDA | 4.91M | 7.72M | 8.68M | 10.16M | 7.24M | 6.53M |
| EBIT | -155.56M | -92.55M | -121.70M | -137.42M | 130.28M | -215.29M |
| EBIT Margin | -87.34% | -159.50% | -180.79% | 31.58% | ||
| Effective Tax Rate | 8.05% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 179.41M | 41.16M | 66.10M | 157.56M | 400.91M | 201.87M |
| Short-Term Investments | 91.29M | 187.64M | 159.67M | 216.77M | 91.32M | 50.74M |
| Cash & Short-Term Investments | 270.70M | 228.80M | 225.78M | 374.33M | 492.23M | 252.61M |
| Receivables | 5.93M | 4.64M | 55.81M | 19.48M | 33.40M | 15.61M |
| Prepaid Expenses | 20.36M | 15.33M | 18.86M | 19.12M | 19.07M | 20.00M |
| Total Current Assets | 298.39M | 248.77M | 300.45M | 412.93M | 544.71M | 288.22M |
| Property, Plant & Equipment | 27.15M | 31.23M | 34.32M | 37.54M | 47.65M | 49.77M |
| Long-Term Investments | 51.78M | 41.79M | 98.43M | 81.93M | 886.00K | 886.00K |
| Goodwill | 12.02M | 12.02M | 12.02M | 12.02M | 12.02M | 12.02M |
| Other Intangible Assets | 998.00K | 1.35M | 4.58M | 7.66M | 8.76M | 3.84M |
| Long-Term Deferred Tax Assets | 4.35M | 4.71M | 4.38M | 3.62M | 1.34M | 3.07M |
| Long-Term Deferred Charges | 17.63M | 17.64M | 18.84M | |||
| Other Long-Term Assets | 2.28M | 6.67M | 8.92M | 7.57M | 15.73M | 12.49M |
| Total Assets | 396.96M | 346.53M | 463.09M | 580.88M | 648.73M | 389.13M |
| Accounts Payable | 27.46M | 4.40M | 3.90M | 6.21M | 7.86M | 5.17M |
| Accrued Expenses | 31.94M | 55.91M | 38.18M | 79.41M | 63.13M | |
| Current Portion of Leases | 3.30M | 3.47M | 2.77M | 4.29M | 3.34M | 1.33M |
| Current Income Taxes Payable | 45.00K | 83.00K | 128.00K | 1.81M | 840.00K | |
| Current Unearned Revenue | 16.44M | 2.42M | 25.59M | 3.70M | 2.35M | |
| Other Current Liabilities | 1.57M | 1.82M | 2.22M | |||
| Total Current Liabilities | 47.24M | 42.32M | 88.29M | 55.76M | 95.62M | 71.85M |
| Long-Term Leases | 12.70M | 14.80M | 15.77M | 22.46M | 24.79M | 31.02M |
| Long-Term Unearned Revenue | 14.61M | 14.61M | 32.94M | 30.59M | 32.94M | |
| Long-Term Deferred Tax Liabilities | 3.74M | 6.03M | 4.76M | 3.30M | 1.79M | 1.57M |
| Other Long-Term Liabilities | 252.91M | 278.00K | 895.00K | 1.61M | 2.98M | 2.65M |
| Total Liabilities | 316.60M | 78.03M | 124.32M | 116.07M | 155.77M | 140.04M |
| Common Stock | 1.14B | 1.11B | 1.02B | 1.01B | 906.76M | 741.15M |
| Additional Paid-In Capital | 116.45M | 114.63M | 152.25M | 142.27M | 151.61M | 197.71M |
| Retained Earnings | -1.17B | -953.16M | -830.34M | -677.44M | -558.76M | -683.10M |
| Comprehensive Income & Other | -6.69M | -6.08M | -6.95M | -6.60M | -6.66M | -6.66M |
| Total Common Equity | 80.37M | 268.50M | 338.77M | 464.81M | 492.96M | 249.09M |
| Shareholders' Equity | 80.37M | 268.50M | 338.77M | 464.81M | 492.96M | 249.09M |
| Total Liabilities & Equity | 396.96M | 346.53M | 463.09M | 580.88M | 648.73M | 389.13M |
| Total Debt | 16.01M | 18.27M | 18.53M | 26.75M | 28.13M | 32.35M |
| Net Cash (Debt) | 306.47M | 252.32M | 305.67M | 429.50M | 464.10M | 220.25M |
| Net Cash Per Share | 4.10 | 3.35 | 4.03 | 6.24 | 7.11 | 4.22 |
| Filing Date Shares Outstanding | 70.96M | 73.75M | 69.58M | 70.57M | 64.04M | 57.74M |
| Total Common Shares Outstanding | 71.41M | 74.64M | 68.96M | 70.12M | 63.06M | 46.63M |
| Working Capital | 251.15M | 206.45M | 212.16M | 357.16M | 449.08M | 216.37M |
| Book Value Per Share | 1.13 | 3.60 | 4.91 | 6.63 | 7.82 | 5.34 |
| Tangible Book Value | 67.36M | 255.13M | 322.18M | 445.13M | 472.19M | 233.24M |
| Tangible Book Value Per Share | 0.94 | 3.42 | 4.67 | 6.35 | 7.49 | 5.00 |
| Machinery | 20.59M | 20.29M | 19.39M | 16.98M | 14.48M | |
| Construction In Progress | 540.00K | 122.00K | 76.00K | 13.26M | ||
| Leasehold Improvements | 15.24M | 15.19M | 20.99M | 20.96M | 9.10M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -149.99M | -81.13M | -122.69M | -118.67M | 124.34M | -211.84M |
| Depreciation & Amortization | 8.63M | 11.11M | 11.19M | 17.30M | 12.00M | 9.58M |
| Other Amortization | 113.00K | |||||
| Asset Writedown & Restructuring Costs | 766.00K | 17.29M | ||||
| Loss (Gain) From Sale of Investments | 667.00K | -167.00K | ||||
| Stock-Based Compensation | 34.03M | 28.03M | 17.79M | 8.10M | 4.01M | 10.76M |
| Other Operating Activities | 6.61M | 1.48M | -2.67M | -158.00K | -266.00K | -1.17M |
| Change in Accounts Receivable | -3.30M | 51.20M | -36.36M | 13.92M | -17.51M | -266.00K |
| Change in Accounts Payable | -6.69M | -23.65M | 14.32M | -44.79M | 26.48M | 16.48M |
| Change in Unearned Revenue | -1.98M | -23.17M | 3.56M | 3.70M | ||
| Change in Income Taxes | -56.00K | -45.00K | -1.68M | 970.00K | 840.00K | |
| Change in Other Net Operating Assets | -7.46M | 3.17M | -10.80M | 632.00K | -5.79M | -15.82M |
| Operating Cash Flow | -119.34M | -33.01M | -110.06M | -118.32M | 144.11M | -192.45M |
| Capital Expenditures | -1.21M | -1.52M | -1.99M | -2.47M | -8.15M | -12.40M |
| Sale (Purchase) of Intangibles | -139.00K | -831.00K | -1.07M | -1.60M | -4.97M | -881.00K |
| Investment in Securities | 94.11M | 29.02M | 41.82M | -203.18M | -40.72M | 157.88M |
| Investing Cash Flow | 92.77M | 26.66M | 38.76M | -207.25M | -53.85M | 144.60M |
| Long-Term Debt Repaid | -14.00K | -17.00K | ||||
| Net Debt Issued (Repaid) | -14.00K | -17.00K | ||||
| Issuance of Common Stock | 32.83M | 23.32M | 9.79M | 81.92M | 109.19M | 8.50M |
| Repurchase of Common Stock | -169.79M | -41.70M | -30.05M | |||
| Other Financing Activities | 244.54M | -181.00K | -174.00K | -53.00K | -596.00K | -470.00K |
| Financing Cash Flow | 107.57M | -18.56M | -20.44M | 81.87M | 108.58M | 8.01M |
| Foreign Exchange Rate Adjustments | 155.00K | -45.00K | 286.00K | 354.00K | 203.00K | -325.00K |
| Net Cash Flow | 81.16M | -24.95M | -91.45M | -243.35M | 199.04M | -40.17M |
| Free Cash Flow | -120.54M | -34.53M | -112.05M | -120.80M | 135.96M | -204.85M |
| Free Cash Flow Margin | -324.68% | -32.58% | -146.85% | -158.92% | 32.96% | -767.82% |
| Free Cash Flow Per Share | -1.61 | -0.46 | -1.48 | -1.75 | 2.08 | -3.93 |
| Levered Free Cash Flow | -65.06M | -12.96M | -52.16M | -91.49M | 89.23M | -146.81M |
| Unlevered Free Cash Flow | -59.76M | -12.96M | -52.16M | -91.49M | 89.23M | -146.81M |
| Cash Income Tax Paid | 1.88M | 1.35M | 3.18M | 165.00K | ||
| Change in Working Capital | -19.49M | 7.50M | -30.97M | -25.57M | 4.01M | 393.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 2.06B | 1.97B | 1.01B | 727.32M | 506.30M | 763.02M |
| Enterprise Value | 1.75B | 1.69B | 653.78M | 458.30M | 370.15M | 485.45M |
| Last Close Price | 28.99 | 26.33 | 14.64 | 10.39 | 7.86 | 16.39 |
| PE Ratio | 4.07 | |||||
| Forward PE | 14.28 | 5.43 | 5.43 | 5.43 | 10.54 | |
| PS Ratio | 55.41 | 18.59 | 13.21 | 9.57 | 1.23 | 28.60 |
| PB Ratio | 25.76 | 7.34 | 2.98 | 1.56 | 1.03 | 3.06 |
| P/TBV Ratio | 30.54 | 7.72 | 3.13 | 1.63 | 1.07 | 3.27 |
| P/FCF Ratio | 3.72 | |||||
| P/OCF Ratio | 3.51 | |||||
| EV/Sales Ratio | 47.15 | 15.95 | 8.57 | 6.03 | 0.90 | 18.20 |
| EV/EBITDA Ratio | 2.69 | |||||
| EV/EBIT Ratio | 2.84 | |||||
| EV/FCF Ratio | 2.72 | |||||
| Debt / Equity Ratio | 0.20 | 0.07 | 0.06 | 0.06 | 0.06 | 0.13 |
| Debt / EBITDA Ratio | 0.19 | |||||
| Debt / FCF Ratio | 0.21 | |||||
| Net Debt / Equity Ratio | -3.81 | -0.94 | -0.90 | -0.92 | -0.94 | -0.88 |
| Net Debt / EBITDA Ratio | 2.03 | 2.98 | 2.71 | 3.38 | -3.38 | 1.05 |
| Net Debt / FCF Ratio | 2.54 | 7.31 | 2.73 | 3.56 | -3.41 | 1.07 |
| Asset Turnover | 0.09 | 0.26 | 0.15 | 0.12 | 0.80 | 0.06 |
| Quick Ratio | 5.86 | 5.52 | 3.19 | 7.06 | 5.50 | 3.73 |
| Current Ratio | 6.32 | 5.88 | 3.40 | 7.41 | 5.70 | 4.01 |
| Return on Equity (ROE) | -72.31% | -26.72% | -30.54% | -24.78% | 33.51% | -64.29% |
| Return on Assets (ROA) | -24.14% | -14.29% | -14.57% | -13.97% | 15.69% | -29.02% |
| Return on Invested Capital (ROIC) | -97.68% | -97.85% | -188.14% | 415.24% | -746.48% | |
| Return on Capital Employed (ROCE) | -44.50% | -30.40% | -32.50% | -26.20% | 23.60% | -67.90% |
| Earnings Yield | -6.93% | -4.12% | -12.17% | -16.32% | 24.56% | -27.76% |
| FCF Yield | -5.86% | -1.75% | -11.11% | -16.61% | 26.85% | -26.85% |
| Buyback Yield / Dilution | 0.84% | 0.61% | -10.19% | -5.54% | -25.16% | -3.47% |